Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study-Reference-Cited by-同舟云学术

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study

Published:2014-07 Issue:1 Volume:168 Page:96-102.e2
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Åkerblom Axel,Eriksson Niclas,Wallentin Lars,Siegbahn Agneta,Barratt Bryan J.,Becker Richard C.,Budaj Andrzej,Himmelmann Anders,Husted Steen,Storey Robert F.,Johansson Åsa,James Stefan K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Prevalence of chronic kidney disease in the United States;Coresh;JAMA,2007

2. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

3. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial;James;Circulation,2010

4. Cystatin C—properties and use as diagnostic marker;Grubb;Adv Clin Chem,2000

5. Multiple loci associated with indices of renal function and chronic kidney disease;Kottgen;Nat Genet,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Random Enrichment of Single-Nucleotide Polymorphisms Associated with Clopidogrel Resistance within Risk Loci Linked to the Severity of Underlying Cardiovascular Diseases: The Role of Admixture;Genes;2023-09-17

2. Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population;Annals of Medicine;2023-05-08

3. Dissecting the Genetic Architecture of Cystatin C in Diversity Outbred Mice;G3 Genes|Genomes|Genetics;2020-07-01

4. Association between cystatin C gene polymorphism and the prevalence of white matter lesion in elderly healthy subjects;Scientific Reports;2020-03-13

5. Персонализированная антитромботическая терапия при стентировании коронарных артерий;Естественные и Технические Науки;2020